| Name: | Bosentan Related Compound B |
| Catalogue No. | VL28003 |
| CAS No. | 174227-14-6 |
| Molecular Formula | C25H25N5O5S |
| Molecular Weight | 507.56 g/mol |
| Status | In-stock |
| IUPAC Name | 4-(tert-Butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide |
| Appearance | White solid |
| Description | Bosentan Related Compound B (CAS No: 174227-14-6) or 4-(tert-Butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide is associate impurity of Bosentan. Bosentan is employed to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) in adults and children 3 years of age and older. |
| References | “Sci-Hub | Improved Large-Scale Synthesis of Bosentan Monohydrate | 10.1080/00304948.2016.1234826.” Hkvisa.net, 2016, sci-hub.hkvisa.net/10.1080/00304948.2016.1234826. |
